Abstract | BACKGROUND: PATIENTS AND METHODS: In this double-blind, randomized, placebo-controlled study, subjects with FC (Rome III criteria) received 1 l/day (4 × 250 ml) of mineral water (Ensinger Schiller Quelle) or carbonated tap water (placebo) for 6 weeks. The primary endpoint was the change in the frequency of bowel movements per week between baseline and visit 4 (after 6 weeks). The prespecified main secondary endpoint was the change in the frequency of bowel movements per week between baseline and visit 3 (after 3 weeks). RESULTS: Efficacy was analyzed in 100 subjects (intention-to-treat). After 6 weeks of treatment there was no statistical difference between the groups (p = 0.163). However, statistical significance was reached after 3 weeks, with an increase in the frequency of bowel movements per week of 2.02 ± 2.22 for the mineral water group compared to 0.88 ± 1.67 for the placebo group (p = 0.005). CONCLUSIONS: A 3-week treatment with 1 l/day of the sulfate-rich mineral water improved the frequency of bowel movements in subjects with FC compared with tap water; however, the difference was no longer significant after 6 weeks. Further evaluation in rigorously designed clinical studies will be necessary to validate the impact of sulfate-rich natural mineral water on FC.
|
Authors | Johannes Naumann, Catharina Sadaghiani, Felix Alt, Roman Huber |
Journal | Forschende Komplementarmedizin (2006)
(Forsch Komplementmed)
Vol. 23
Issue 6
Pg. 356-363
( 2016)
ISSN: 1661-4127 [Electronic] Switzerland |
PMID | 27924798
(Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial)
|
Copyright | © 2016 S. Karger GmbH, Freiburg. |
Chemical References |
- Carbonated Water
- Magnesium Sulfate
|
Topics |
- Adult
- Carbonated Water
(therapeutic use)
- Chronic Disease
- Colonic Diseases, Functional
(therapy)
- Constipation
(therapy)
- Dose-Response Relationship, Drug
- Double-Blind Method
- Female
- Follow-Up Studies
- Germany
- Guideline Adherence
- Humans
- Magnesium Sulfate
(therapeutic use)
- Male
- Middle Aged
- Prospective Studies
|